Frailty Tied to Gender Gap in Liver Transplant Wait-List Mortality
Women with cirrhosis displayed worse frailty scores despite similar liver disease severity Women...
Transplantation
Oxygen Delivered During Donor Kidney Preservation is Easy, Safe, Adds Minimal Cost
Also associated with improved outcomes Supplemental oxygen delivered along with hypothermic...
Heart Transplant: UNOS Policy Cut Wait Times, Mortality, but Post-transplant Survival Increased
Experts call for reconsideration of 2018 policy change Changes in the U.S. United Network for...
Considering Lung Transplant Frailty
The goal of lung transplantation is to improve quality of life (QOL) and extend survival for patients with advanced lung disease. The degree to which individual lung transplant recipients achieve these goals is highly variable....
CME – Conference Highlights: AATS 2020
This course discusses the key findings of five studies presented at the 2020 virtual Annual...
Liver Transplant Outcomes with ’Marginal’ and Benchmark Allografts Similar
Study findings encourage aggressive use of liver allografts Outcomes among liver transplant...
Conference Highlights: AATS 2020
New research was presented at AATS 2020, the virtual Annual Meeting of the American Association...
Sex Inequities in Liver Transplant Result Longer Wait Times, Death for Women
Mitigating geographic disparities not enough Sex-based inequities in access to liver transplants won’t necessarily be solved by just enacting policies designed to mitigate geographic disparities in liver allocations.In...
Covid-19: High Mortality Seen in Heart Transplant Patients
Small series points to complex issues for HT patients with Covid-19 Over an 8-week period beginning March 1, doctors at a large academic medical center in New York confirmed SARS-CoV-2 infection in 28 heart transplant patients,...
Preemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Preemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Preemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
